Towards Healthcare
Cell Freezing Media Market to Grow 8.6% CAGR till 2035

Cell Freezing Media Market Drives Innovation in Cryopreservation

According to market projections, the cell freezing media sector is expected to grow from USD 1.30 billion in 2025 to USD 2.97 billion by 2035, reflecting a CAGR of 8.6%. The cell freezing media market is growing due to the rising usage of cells in various healthcare services, including therapeutics and diagnostics. North America leads the market due to rising focus on genomics and demand for cell and gene therapies. 

Content

  • Last Updated: 21 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

The cell freezing media market holds a valuation of USD 1.42 billion as of 2026, and will expand to USD 2.97 billion by 2035, achieving a CAGR of 8.6% between 2026 and 2035.

North America is currently leading the cell freezing media market share by 40-46% approx due to a strong presence of CDMOs and CMOs, which ensures the smooth flow of work in life sciences.

The cell freezing media market comprises 6 segments by product or type, by application, by formulation or technology, by end-user, by distribution channel, and by region.

Some key players include Thermo Fisher Scientific, BioLife Solutions, Merck KGaA or MilliporeSigma, STEMCELL Technologies, Corning Life Sciences including Axygen, Falcon consumables, Bio-Rad Laboratories, CTS Bio, etc.

Key trends include rising demand for precision medicine and growing research in bioinformatics.

A process known as cryopreservation involves suspending cells in a mixture of salts and a low-molecular-weight low-MW) organic compound, cooling them to extremely low subzero temperatures typically −196°C in liquid nitrogen, storing them for a while, and then warming and recovering them to return to normal.

There are two methods for freezing tissue: cryopreservation, which uses specialized freezing media and controlled temperature reduction for long-term storage, and rapid freezing, which uses coolants like liquid nitrogen or dry ice for intraoperative diagnosis.
Any Questions